超罕见肉瘤的方法:定义,诊断和治疗方法
Alessandra Merlini1, Angelo Paolo Dei Tos2, Pan Pantziarka3
1Department of Oncology, University of Turin, Regione Gonzole 10, 10043 Orbassano, Turin, Italy; Medical Oncology, San Luigi Gonzaga University Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.
超罕见的肉瘤,影响百万分之一,对研究和治疗提出独特的挑战. 本综述为临床医生和研究人员提供了关于它们的复杂性,全球差异以及未来管理策略的见解.
科学领域:
- 在瘤学瘤学.
- 肉瘤研究研究 肉瘤研究
- 罕见疾病 罕见疾病
背景情况:
- 超罕见的肉瘤被定义为每年每百万居民发生1例的发病率.
- 它们的稀有性阻碍了基因组特异性随机对照试验的发展.
- 了解这些挑战对于推进患者护理至关重要.
研究的目的:
- 为临床医生和研究人员提供超罕见瘤的实用信息和参考资料.
- 为了阐明这些罕见瘤的复杂性,全球治疗差异和管理选择.
- 突出患者歧视和创新药物的批准方面的差异.
主要方法:
- 这份手稿是一份复习和参考指南.
- 它综合了关于定义,诊断挑战和治疗方法的现有知识.
- 它分析了治疗和药物批准方面的差异.
主要成果:
- 稀有性是对超稀有类肉瘤进行特定研究的重要障碍.
- 在全球范围内,可用的治疗选择和管理策略存在差异.
- 患者面临歧视,创新的药物在全球范围内获得不同程度的批准.
结论:
- 发展对超罕见肉瘤的全面了解对于改善患者的治疗结果至关重要.
- 解决全球差距和倡导公平获得创新治疗方法至关重要.
- 未来的努力应集中在合作研究和政策变化上,以造福超罕见瘤患者.
更多相关视频
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
